학술논문
Response to letter: "Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule" by Suzuki et al.
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
18785883